AVITA Medical (AVHHL) Net Income towards Common Stockholders (2018 - 2026)
AVITA Medical's (AVHHL) quarterly Net Income towards Common Stockholders came in at -$7.7 million in Q2 2026, up 22.75% on a YoY basis from -$6.2 million in Q2 2025, and down 443.86% quarter-over-quarter from -$1.4 million in Q4 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported Net Income towards Common Stockholders for 9 consecutive years, with -$7.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 22.75% year-over-year to -$7.7 million; the trailing twelve-month figure through Jun 2026 stood at -$32.2 million (up 16.51% YoY), and the FY2025 full-year result was -$38.4 million, up 21.39% from the prior year.
- Net Income towards Common Stockholders declined to -$7.7 million in Q2 2026 per AVHHL's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $1.4 million in Q4 2024 and bottomed at -$18.7 million in Q1 2024.
- Historically, Net Income towards Common Stockholders has averaged -$9.5 million across 5 years, with a median of -$9.3 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders jumped 116.08% in 2024, then plunged 197.78% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$4.2 million in 2022, then sank by 114.84% to -$9.0 million in 2023, then soared by 116.08% to $1.4 million in 2024, then slumped by 197.78% to -$1.4 million in 2025, then sank by 443.86% to -$7.7 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$7.7 million, -$1.4 million, and -$13.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.01 Bn | 178.41 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 126.03 Bn | 120.82 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.94 Bn | 110.12 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.48 Bn | 102.01 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 67.55 Bn | 67.01 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.67 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 34.13 Bn | 32.68 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.90 Bn | 29.95 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | -7.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.66 Mn |
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | -13.19 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -13.86 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | -16.21 Mn |
| Jun 30, 2024 | -15.39 Mn |
| Mar 31, 2024 | -18.66 Mn |
| Dec 31, 2023 | -8.96 Mn |
| Sep 30, 2023 | -8.71 Mn |
| Jun 30, 2023 | -10.38 Mn |
| Mar 31, 2023 | -9.22 Mn |
| Dec 31, 2022 | -4.17 Mn |
| Sep 30, 2022 | -5.59 Mn |
| Mar 31, 2022 | -9.46 Mn |
| Sep 30, 2021 | -16.66 Mn |
| Jun 30, 2021 | -10.72 Mn |
| Mar 31, 2021 | -6.00 Mn |
| Dec 31, 2020 | -5.64 Mn |